Reason Why Everyone Is Speaking Of ARAF

Матеріал з HistoryPedia
Перейти до: навігація, пошук

In addition, this variant contributes to the rare 4-site haplotype (Table ?(Table1)1) that (a) only appears in families 4 and 15, and (b) lies directly beneath the PPL peak (see Figure ?Figure2).2). Also, note that family 4 provides some evidence for linkage at this locus (maximum PPL = 7%). Finally, to compare our NGLA methods to a commonly used FBA, we carried out the 4-step filtering procedure described in Background above. Similar to our NGLA methods, FBA identified variant 3_31590155. However, FBA also found 22 other variants spread across the entire chromosome (see Figure ?Figure2).2). Interestingly, rs7624739 (PPLD = 14%) was missed by FBA, and because it is not among the GWAS SNPs, it would also have been missed in a genome-wide association analysis. Table 1 Characteristics of Ceritinib manufacturer sequence variants identified by NGLA methods Discussion It is important to remember that although our methodology-related results should be generalizable, our SBP-related results are primarily ARAF of a preliminary nature. Therefore, before any biological conclusions are drawn, the following caveats should be considered. First, the sequence data for Ped15 were entirely imputed. Ideally, the quality of that imputation--especially the existence and segregation of the 4-site haplotype--should be verified experimentally in the lab. Second, we did not adjust for measured covariates, which may have influenced some part (or all) of our results. Third, we confined our analyses to a 4-cM region of chromosome 3, which means that candidate genes in other regions (eg, MAP4 at 69 cM) cannot be excluded. As such, candidate genes in these regions deserve further investigation. Also, to the extent possible, we examined the sensitivity of our methods to MCMC error and to different phenotype definitions. In each case, our conclusions remained qualitatively the same. Our NGLA approach to the analysis of sequence data led check details us to a manageable number of intronic (and intergenic) variants that lie in an excellent candidate gene: OSBPL10. Furthermore, the 4-site rare haplotype that we identified, was not seen in any of the unlinked families, but was seen in one of the other linked families. Although the commonly used FBA identified OSBPL10, it missed the strongest PPLD association: 3_31907631 (rs7624739), and it found several variants in apparently unlinked regions of chromosome 3 (PPL